Searched for
BHARAT BIOTECH
Tata Chemicals CEO R Mukundan takes over as CII president for 2026-27R Mukundan, CEO of Tata Chemicals, has assumed the presidency of the Confederation of Indian Industry (CII) for 2026-27, succeeding Rajiv M...- Bharat Biotech bets on vaccines to fight drug resistance, eyes post-Covid growthHyderabad-based Bharat Biotech is developing novel vaccines to combat antimicrobial resistance (AMR), a significant global health threat. T...
- Vaccine maker Bharat Biotech said to mull $500 million IPOIndian vaccine developer Bharat Biotech International Ltd. is considering an initial public offering that may raise more than $500 million,...
- Bharat Biotech, Biofabri in tech transfer deal for TB vaccineMTBVAC, the TB vaccine, has undergone Phase I and II clinical trials in India. The vaccine has demonstrated safety and immunogenicity. Base...
- Bharat Biotech, GSK join hands to develop vaccine for severe diarrhoeaBharat Biotech and GSK plc have partnered to develop a vaccine for Shigellosis, a severe bacterial diarrhea. The altSonflex1-2-3 vaccine ca...
- Bharat Biotech launches oral cholera vaccine Hillchol after positive phase 3 trialBharat Biotech unveiled Hillchol, a new single-strain oral cholera vaccine, developed with Hilleman Laboratories. Addressing the high globa...
- Bharat Biotech credited ICMR, NIV as Covaxin co-inventors after missing them initially: GovernmentResponding to Trinamool Congress member Sougata Roy, who had asked whether the government took any punitive action against the company for ...
- Bharat Biotech, Bilthoven Biologicals collaborate for oral polio vaccines production, supplyBharat Biotech on Tuesday said it has collaborated with the Netherlands-based Bilthoven Biologicals B.V, a wholly-owned arm of Serum Instit...
- Japan recognises Covaxin to facilitate travel from April 10: Bharat BiotechJapan has included Bharat Biotech's Covaxin in the list of recognised vaccines, a move aimed at facilitating travel between the two countri...
- No impact on efficacy and safety of Covaxin: Bharat Biotech after WHO suspension"For the millions who have received COVAXIN, the vaccine certificates issued still stand valid as there is no impact on efficacy and safety...
- Bharat Biotech's Covaxin gets WHO okay for emergency useHyderabad-based Bharat Biotech, which has developed Covaxin, submitted EOI (Expression of Interest) to the WHO on April 19 for the vaccine'...
- Awaiting regulatory approvals to launch Covaxin for children: Bharat Biotech"This represents one of the first approvals worldwide for COVID-19 vaccines for the 2-18 age group. Bharat Biotech sincerely thanks the DCG...
- Decision on Bharat Biotech's Covaxin EUL in October, says WHOThe latest 'Status of COVID-19 vaccines within WHO EUL/PQ evaluation process' guidance document dated September 29 on the WHO website said ...
- Bharat Biotech, IVI launch Chikungunya Vaccine Phase 2/3 trial in Costa RicaCEPI first partnered with IVI and Bharat Biotech in June 2020, providing up to USD 14.1 million for vaccine manufacturing and clinical deve...
- Covaxin receives GMP certificate from Hungary: Bharat BiotechBharat Biotech intends to submit documentation for emergency use authorisation to several additional countries worldwide, the company said.
- COVAXIN: News reports on submitting Phase-3 data to WHO is incorrect, says Bharat BiotechBharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use...
- How Krishna Ella built Bharat Biotech and why the company is at a tipping pointBharat Biotech’s Covaxin is India’s first indigenous coronavirus vaccine. The DCGI’s approval of Covaxin, despite it not having phase-3 cli...
- Bharat Biotech's top brass calls on vice presidentThe indigenous, inactivated vaccine is being developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) bio-containment faci...
- Bharat Biotech completes recruitment of 13,000 volunteers for Phase III trials of CovaxinBharat Biotech has signed up 13,000 volunteers for the Phase 3 trial, backed by India's government medical research body, and is progressin...
- Bharat Biotech begins Phase-III trials for COVID-19 vaccine, Covaxin, with 26,000 volunteers"This is India's first phase-III efficacy study for a Covid-19 vaccine, and the largest phase-III efficacy trial ever conducted in India," ...
Load More
